Guardians of the oral and nasopharyngeal galaxy: IgA and protection against SARS-CoV-2 infection

Guardians of the oral and nasopharyngeal galaxy: IgA and protection against SARS-CoV-2 infection

Bibliographic Details
Main Authors:	Sheikh‐Mohamed, Salma, Sanders, Erin C., Gommerman, Jennifer L., Tal, Michal Caspi
Other Authors:	Massachusetts Institute of Technology. Department of Biological Engineering
Format:	Article
Published:	Wiley 2022
Online Access:	https://hdl.handle.net/1721.1/145701

Similar Items

Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients
by: Bernadette Crescenzo-Chaigne, et al.
Published: (2021-12-01)

IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection
by: Isabella Quinti, et al.
Published: (2021-04-01)

The Impact of IgA and the Microbiota on CNS Disease
by: Annie Pu, et al.
Published: (2021-09-01)

IgA Nephropathy After SARS-CoV-2 Vaccination
by: Matthew Abramson, et al.
Published: (2021-09-01)

Development of IgA vasculitis after SARS‐CoV‐2 vaccination
by: Yasuaki Ogura, et al.
Published: (2022-10-01)

Serum EA-IgA and d-dimer, but not VCA-IgA, are associated with prognosis in patients with nasopharyngeal carcinoma: a meta-analysis
by: Tianhao Liang, et al.
Published: (2021-06-01)

SARS-CoV-2 induced IgA vasculitis confirmed with SARS-CoV-2 tissue testing
by: Ahmed N. Ansari, MD, et al.
Published: (2024-01-01)

Hematuria in patients with IgA nephropathy after vaccine for SARS-CoV-2
by: Leonardo Calle Garcia, et al.
Published: (2023-09-01)

Anti-SARS-Cov-2 IgA Response in Tears of COVID-19 Patients
by: Elisabetta Caselli, et al.
Published: (2020-11-01)

Heterologous SARS‐CoV‐2 IgA neutralising antibody responses in convalescent plasma
by: Samantha K Davis, et al.
Published: (2022-01-01)

Oral-nasopharyngeal dendritic cells mediate T cell-independent IgA class switching on B-1 B cells.
by: Kosuke Kataoka, et al.
Published: (2011-01-01)

Development of an Oral IgA Response against SARS-CoV-2 Following Immunization with Different COVID-19 Vaccines
by: Irene Soffritti, et al.
Published: (2023-11-01)

Development of SARS-CoV-2 specific IgG and IgA antibodies in serum and milk with different SARS-COV-2 vaccines in lactating women
by: Carolina Lechosa-Muñiz, et al.
Published: (2023-01-01)

Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not enhance viral infection.
by: Natasha M Clark, et al.
Published: (2022-01-01)

Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not enhance viral infection
by: Natasha M. Clark, et al.
Published: (2022-01-01)

Abnormal Aspects of IgA in IgA Nephropathy
by: Akash Nabil, et al.
Published: (2000-01-01)

Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum
by: Oscar Bladh, et al.
Published: (2024-03-01)

IgA-Dominant Infection-Associated Glomerulonephritis Following SARS-CoV-2 Infection
by: Aurora Pérez, et al.
Published: (2021-03-01)

Inhibition of invasive salmonella by orally administered IgA and IgG monoclonal antibodies.
by: Angelene F Richards, et al.
Published: (2020-03-01)

Is SARS-CoV-2 Neutralized More Effectively by IgM and IgA than IgG Having the Same Fab Region?
by: Yalcin Pisil, et al.
Published: (2021-06-01)

IgA Vasculitis and IgA Nephropathy: Same Disease?
by: Evangeline Pillebout
Published: (2021-05-01)

IgG and IgA Antibodies Post SARS-CoV-2 Vaccine in the Breast Milk and Sera of Breastfeeding Women
by: Federica Scrimin, et al.
Published: (2022-01-01)

Salivary IgA and IgG in oral lichen planus and oral lichenoid reactions diseases
by: Parichehr Ghaleyani, et al.
Published: (2012-01-01)

Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2
by: Xunyan Ye, et al.
Published: (2021-10-01)

Combination of Plasma MIF and VCA-IgA Improves the Diagnostic Specificity for Patients With Nasopharyngeal Carcinoma
by: Ning Xue MM, et al.
Published: (2020-06-01)

Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity
by: Cyrielle Holuka, et al.
Published: (2021-05-01)

Evaluation of Anti-SARS-CoV-2 IgA in the Conjunctival Secretions of COVID-19 Patients
by: Mahmoud H, et al.
Published: (2021-05-01)

Increased Urinary IgA in Paediatric IgA Vasculitis Nephritis
by: Julien Marro, et al.
Published: (2022-11-01)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
by: Yoshihito Nihei, et al.
Published: (2023-04-01)

Intramuscular vaccination against SARS-CoV-2 transiently induces neutralizing IgG rather than IgA in the saliva
by: Stephan Winklmeier, et al.
Published: (2024-02-01)

Anti-RBD IgA and IgG Response and Transmission in Breast Milk of Anti-SARS-CoV-2 Vaccinated Mothers
by: Felicia Trofin, et al.
Published: (2022-02-01)

Seroprevalence of IgA and IgG against SARS-CoV-2 and Risk Factors in Workers from Public Markets of Guatemala
by: Laura M. Grajeda, et al.
Published: (2023-09-01)

Prior COVID-19 Immunization Does Not Cause IgA- or IgG-Dependent Enhancement of SARS-CoV-2 Infection
by: Melyssa Yaugel-Novoa, et al.
Published: (2023-03-01)

Maternal transfer of IgA and IgG SARS-CoV-2 specific antibodies transplacentally and via breast milk feeding.
by: Mohammad M Sajadi, et al.
Published: (2023-01-01)

Maternal transfer of IgA and IgG SARS-CoV-2 specific antibodies transplacentally and via breast milk feeding
by: Mohammad M. Sajadi, et al.
Published: (2023-01-01)

IgA and IgG antibodies in SARS-CoV-2 vaccinated health workers by a homemade ELISA diagnostic test
by: Luigi Tagliaferro, et al.
Published: (2021-06-01)

Performance of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies in South Africa.
by: Maemu P Gededzha, et al.
Published: (2021-01-01)

Multiplex Antibody Analysis of IgM, IgA and IgG to SARS-CoV-2 in Saliva and Serum From Infected Children and Their Close Contacts
by: Carlota Dobaño, et al.
Published: (2022-01-01)

The Functional Role of IgA in the IgM/IgA-Enriched Immunoglobulin Preparation Trimodulin
by: Fabian Bohländer, et al.
Published: (2021-12-01)

Development of a Duplex Serological Multiplex Assay for the Simultaneous Detection of Epstein-Barr Virus IgA and IgG Antibodies in Nasopharyngeal Carcinoma Patients
by: Jennifer Schieber, et al.
Published: (2023-04-01)